The detection of glucocorticoid receptors in breast cancer by immunocytochemical and biochemical methods

dc.contributor.authorIoannidis, C.en
dc.contributor.authorPapamichail, M.en
dc.contributor.authorAgnanti, N.en
dc.contributor.authorGaras, J.en
dc.contributor.authorTsawdaroglou, N.en
dc.contributor.authorSekeris, C. E.en
dc.date.accessioned2015-11-24T19:42:09Z
dc.date.available2015-11-24T19:42:09Z
dc.identifier.issn0020-7136-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24595
dc.rightsDefault Licence-
dc.subjectBreast Neoplasms/*metabolism/pathologyen
dc.subjectDexamethasone/metabolismen
dc.subjectFemaleen
dc.subjectFibrocystic Breast Disease/metabolism/pathologyen
dc.subjectHumansen
dc.subjectImmunoenzyme Techniquesen
dc.subjectReceptors, Glucocorticoid/*analysisen
dc.subjectReceptors, Steroid/*analysisen
dc.titleThe detection of glucocorticoid receptors in breast cancer by immunocytochemical and biochemical methodsen
heal.abstractGlucocorticoid receptors have been detected in 90 human breast tumors and tumor-like conditions by the immunoperoxidase method using a specific antibody against the glucocorticoid receptor isolated from rat thymocytes. In some of the specimens the [3H]-dexamethasone binding assay was also performed and the results obtained were compared with those of the immunoperoxidase method. When the biochemical method was used, no strict correlation between the degree of binding of [3H]-dexamethasone and malignancy on the basis of histological findings could be demonstrated. In contrast, the immunoperoxidase method was in full agreement with the histological type of the tumor. Thus, nearly all malignant breast tumors (carcinomas) were positive by the immunoperoxidase method to a vary degree. Most of the examined benign tumor-like conditions (fibrocystic disease) were found to be negative. Intermediate situations, such as atypical duct of lobular hyperplasia, papillomatosis etc, were mostly positive. These findings suggest that ther immunoperoxidase method, part from its usefulness for the detection of glucocorticoid receptors in breast tissue, may be used as an early biological marker to detect early conversion of normal to hyperplastic tissue and/or malignancy of the mammary gland.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/7037657-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1002/ijc.2910290206/asset/2910290206_ftp.pdf?v=1&t=h1sz18ji&s=605ffe4282e6b460475b2b979179c966fc431f3a-
heal.journalNameInt J Canceren
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1982-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: